Targeted therapy in Coronavirus disease 2019 (COVID-19): Implication from cell and gene therapy to immunotherapy and vaccine

M Shirzad, M Nourigorji, A Sajedi, M Ranjbar… - International …, 2022 - Elsevier
Severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) is a highly pathogenic and
transmissible virus. Infection caused by SARS-CoV-2 known as Coronavirus disease 2019 …

An update to “novel therapeutic approaches for treatment of COVID-19”

N Hossein-Khannazer, B Shokoohian… - Journal of Molecular …, 2021 - Springer
Although the exact mechanism of pathogenesis in COVID-19 is not fully understood,
cytokine storm following viral infection plays an important role in the initiation and …

Emerging therapeutic approaches to combat COVID-19: present status and future perspectives

K Vivekanandhan, P Shanmugam… - Frontiers in Molecular …, 2021 - frontiersin.org
Coronavirus disease (COVID-19) has emerged as a fast-paced epidemic in late 2019 which
is disrupting life-saving immunization services. SARS-CoV-2 is a highly transmissible virus …

Novel therapeutic approaches for treatment of COVID-19

N Hossein-Khannazer, B Shokoohian… - Journal of Molecular …, 2020 - Springer
To date, there is no licensed treatment or approved vaccine to combat the coronavirus
disease of 2019 (COVID-19), and the number of new cases and mortality multiplies every …

New therapeutic approaches for SARS-CoV-2/COVID-19

AJ Rodriguez-Morales, AN Barbosa… - Frontiers in …, 2023 - frontiersin.org
After three years and a half since the pandemic due to the Severe Acute Respiratory
Syndrome coronavirus 2 (SARS-CoV-2) causing Coronavirus Disease 2019 (COVID-19) …

A global picture: therapeutic perspectives for COVID-19

VP Chavda, C Kapadia, S Soni, R Prajapati… - …, 2022 - Taylor & Francis
The COVID-19 pandemic is a lethal virus outbreak by severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2), which has severely affected human lives and the global …

[HTML][HTML] Therapeutics for COVID-19 and post COVID-19 complications: An update

D Basu, VP Chavda, AA Mehta - Current Research in Pharmacology and …, 2022 - Elsevier
Since its inception in late December 2020 in China, novel coronavirus has affected the
global socio-economic aspect. Currently, the world is seeking safe and effective treatment …

[HTML][HTML] Roles of existing drug and drug targets for COVID-19 management

AG Ayele, EF Enyew, ZD Kifle - Metabolism Open, 2021 - Elsevier
In December 2019, a highly transmissible, pneumonia epidemic caused by a novel
coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), erupted in …

[HTML][HTML] Potential therapeutic agents to COVID-19: An update review on antiviral therapy, immunotherapy, and cell therapy

MS Mirtaleb, AH Mirtaleb, H Nosrati… - Biomedicine & …, 2021 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China,
in December 2020 and coronavirus disease 19 (COVID-19) was later announced as …

Coronavirus disease 2019 (COVID-19): Immunological approaches and emerging pharmacologic treatments

P Goodarzi, F Mahdavi, R Mirzaei, H Hasanvand… - International …, 2020 - Elsevier
The SARS-CoV-2 virus is an etiological agent of pandemic COVID-19, which spreads
rapidly worldwide. No proven effective therapies currently exist for this virus, and efforts to …